Fennec Pharmaceuticals (FENC) Assets Average (2011 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Assets Average came in at $59.9 million in Q4 2025, up 15.35% YoY from $51.9 million in Q4 2024, and up 27.27% on a QoQ basis from $47.1 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Assets Average (2011 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 15 years of Assets Average data on file, last reported at $59.9 million in Q4 2025.
- Quarterly Assets Average rose 15.35% year-over-year to $59.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.9 million (up 15.35% YoY) and the FY2025 annual result came in at $57.7 million, up 60.84% from the prior year.
- Assets Average improved to $59.9 million in Q4 2025, from $47.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $66.2 million in Q2 2024 to a low of $17.4 million in Q2 2022.
- A 5-year average of $35.6 million and a median of $28.3 million in 2021 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average tumbled 37.94% — and 2024, when it soared 220.8%.
- Tracing FENC's Assets Average over 5 years: stood at $24.2 million in 2021, then advanced by 18.44% to $28.7 million in 2022, then declined by 18.33% to $23.4 million in 2023, then soared by 121.74% to $51.9 million in 2024, then increased by 15.35% to $59.9 million in 2025.
- The last three Assets Average figures came in at $59.9 million (Q4 2025), $47.1 million (Q3 2025), and $45.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 73.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.15 Mn |
| Dec 31, 2025 | 59.91 Mn |
| Sep 30, 2025 | 47.07 Mn |
| Jun 30, 2025 | 45.64 Mn |
| Mar 31, 2025 | 45.67 Mn |
| Dec 31, 2024 | 51.93 Mn |
| Sep 30, 2024 | 61.04 Mn |
| Jun 30, 2024 | 66.18 Mn |
| Mar 31, 2024 | 48.03 Mn |
| Dec 31, 2023 | 23.42 Mn |
| Sep 30, 2023 | 19.71 Mn |
| Jun 30, 2023 | 20.63 Mn |
| Mar 31, 2023 | 24.38 Mn |
| Dec 31, 2022 | 28.68 Mn |
| Sep 30, 2022 | 22.99 Mn |
| Jun 30, 2022 | 17.36 Mn |
| Mar 31, 2022 | 20.78 Mn |
| Dec 31, 2021 | 24.21 Mn |
| Sep 30, 2021 | 27.06 Mn |
| Jun 30, 2021 | 27.97 Mn |